• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Five Prime Therapeutics downgraded by Jefferies Financial Group

    3/4/21 8:05:48 PM ET
    $FPRX
    Major Pharmaceuticals
    Health Care
    Get the next $FPRX alert in real time by email
    Jefferies Financial Group downgraded Five Prime Therapeutics from Buy to Hold
    Get the next $FPRX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FPRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FPRX
    SEC Filings

    See more
    • SEC Form SC 13G/A filed by Five Prime Therapeutics, Inc. (Amendment)

      SC 13G/A - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Subject)

      5/17/21 4:34:51 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 15-12B filed by Five Prime Therapeutics, Inc.

      15-12B - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Filer)

      4/26/21 4:11:57 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form EFFECT filed by Five Prime Therapeutics, Inc.

      EFFECT - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Filer)

      4/22/21 12:15:14 AM ET
      $FPRX
      Major Pharmaceuticals
      Health Care

    $FPRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Sarena Francis Willard received a gift of 2,385 units of Common Stock, was granted 66,000 units of Common Stock, disposed of $6,530,414 worth of Common Stock back to the company (171,853 units at $38.00) and gifted 20,459 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy withholding obligation

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 8:04:26 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: Smith David V was granted 66,000 units of Common Stock and disposed of $5,279,986 worth of Common Stock back to the company (138,947 units at $38.00) , decreasing direct ownership by 100% to 0 units to satisfy tax liability

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:57:02 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care
    • SEC Form 4: Collins Helen Louise disposed of $5,150,786 worth of Common Stock back to the company (135,547 units at $38.00) , gifted 8,085 units of Common Stock and was granted 66,000 units of Common Stock, decreasing direct ownership by 100% to 0 units to satisfy tax liability

      4 - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Issuer)

      4/19/21 7:53:58 PM ET
      $FPRX
      Major Pharmaceuticals
      Health Care